1. Home
  2. EVI vs TRDA Comparison

EVI vs TRDA Comparison

Compare EVI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$17.62

Market Cap

234.7M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.66

Market Cap

254.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
TRDA
Founded
1959
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.7M
254.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EVI
TRDA
Price
$17.62
$6.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$35.00
$21.00
AVG Volume (30 Days)
34.1K
668.2K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
1.81%
N/A
EPS Growth
32.43
N/A
EPS
0.31
N/A
Revenue
$389,830,000.00
$25,421,000.00
Revenue This Year
$15.53
$39.97
Revenue Next Year
$3.83
$50.80
P/E Ratio
$56.45
N/A
Revenue Growth
10.26
N/A
52 Week Low
$15.61
$4.93
52 Week High
$34.82
$16.45

Technical Indicators

Market Signals
Indicator
EVI
TRDA
Relative Strength Index (RSI) 46.11 34.10
Support Level $16.78 $5.75
Resistance Level $21.36 $6.90
Average True Range (ATR) 1.41 0.53
MACD 0.08 0.01
Stochastic Oscillator 44.51 55.03

Price Performance

Historical Comparison
EVI
TRDA

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: